Plain-English translation of NCT07155954 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is evaluating a new ultrasound technology called super-resolution ultrasound microvascular imaging to see if it can better distinguish between benign (non-cancerous) and malignant (cancerous) lymph nodes. The study will compare how blood flows through benign versus cancerous lymph nodes using this advanced imaging technique. Researchers hope this imaging approach could help doctors make more accurate diagnoses without always needing a biopsy.
Currently, doctors sometimes struggle to tell whether a swollen lymph node is benign or cancerous using standard ultrasound alone, which can lead to unnecessary biopsies or missed diagnoses. This new imaging technology may provide clearer information about blood flow patterns that differ between benign and cancerous nodes, potentially improving diagnostic accuracy.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will receive the new advanced ultrasound imaging of your lymph nodes, likely during a visit before or around the time of your planned biopsy or surgery. The imaging itself is non-invasive and similar to a regular ultrasound, though it may take longer and use contrast dye to help visualize blood flow. Your participation helps researchers understand whether this new technology can improve how doctors diagnose lymph node problems.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China